Reference pricing or HTA for obtaining best value from drugs? News item 02 February 2013 Pages: 4 - 4
Insulin aspart and human insulin: a long-term economic comparison News item 02 February 2013 Pages: 5 - 5
Insulin aspart/insulin protamine aspart cost-effective for T2DM Clinical study 02 February 2013 Pages: 8 - 8
Insulin aspart delivers versus human insulin in pregnancy Clinical study 02 February 2013 Pages: 9 - 9
Pegfilgrastim least costly for chemo-induced neutropenia Clinical study 02 February 2013 Pages: 9 - 9
Institutional academic-industry relationships prevalent and risky Comment 02 February 2013 Pages: 10 - 10
Variation in costs with warfarin, other anticoagulants Clinical study 02 February 2013 Pages: 12 - 12
Laughter therapy provided substantial improvements in health-related quality of life among patients requiring haemodialysis, Clinical study 02 February 2013 Pages: 12 - 12
“[I]nfluenza vaccination can reduce influenza-attributable medical visits for children significantly, even in years with modest vaccine efficacy”, Clinical study 02 February 2013 Pages: 13 - 13
Low health literacy costs the US economy somewhere in the region of $US106-$US236 billion annually, Media release 02 February 2013 Pages: 13 - 13
The UK's policy of prescribing drugs based on cost effectiveness breaches the rights of elderly people, News item 02 February 2013 Pages: 14 - 14
The UK NHS has announced that a routine HPV immunisation programme for girls aged 12-13 years will be implemented from September 2008. Media release 02 February 2013 Pages: 14 - 14